ReviewJournal of asthma and allergy2013
Safety of bronchodilators and corticosteroids for asthma during pregnancy: what we know and what we need to do better.
Review in Journal of asthma and allergy, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
12 citing papers in PubMed, 1 synthesis or guideline pooled it.
- A Rare Complication during Vaginal Delivery, Hamman's Syndrome: A Case Report and Systematic Review of Case Reports.International journal of environmental research and public health · 2022Pooled it
- Prescription Drugs in Pregnancy and Congenital Malformations: A Population-Based Safety Screening Study.Pharmacoepidemiology and drug safety · 2025Article
- Bronchodilators and inhaled corticosteroids use in major global bronchiectasis registries.Journal of thoracic disease · 2025Article
- Review
- Differences in the Association Between Oral Glucocorticoids and Risk of Preterm Birth by Data Source: Reconciling the Results.Arthritis care & research · 2022Article
- "I know my body better than you:" patient focus groups to inform a decision aid on oral corticosteroid use during pregnancy.Pharmacoepidemiology and drug safety · 2021Article
- Oral Corticosteroids and Risk of Preterm Birth in the California Medicaid Program.The journal of allergy and clinical immunology. In practice · 2021Article
- Oral corticosteroid use during pregnancy and risk of preterm birth.Rheumatology (Oxford, England) · 2020Article
- On the use of the outcome variable "small for gestational age" when gestational age is a potential mediator: a maternal asthma perspective.BMC medical research methodology · 2017Article
- Asthma medication use during pregnancy, wheeze and estimated exposure to ambient nitrogen dioxide.The European respiratory journal · 2015Article
- Experimentation with aerosol bonsetan, pirfenidone, treprostinil and sidenafil.Journal of thoracic disease · 2014Article
- Asthma Medication Use and Risk of Birth Defects: National Birth Defects Prevention Study, 1997-2011.The journal of allergy and clinical immunology. In practiceArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Asthma is a common medical condition complicating pregnancy with potentially serious effects on pregnancy outcome. The aim of this review is to provide an update on efficacy and safety of asthma medications, primarily bronchodilators and corticosteroids, used during pregnancy with focus on pregnancy outcome, and, furthermore, to discuss limitations of available studies and point to possible improvements in future studies. A planned series of systematic searches was conducted using the PubMed database. Use of short-acting β2-agonists has generally been established as safe, and the few studies stating otherwise appear to have, perhaps critical, methodological limitations. The safety of long-acting β2-agonists remains to be further investigated, and the few available studies have methodological limitations and, therefore, provide no definite answers, although a very recent study supports the safety of add-on long-acting β2-agonists to inhaled corticosteroids. Inhaled corticosteroids are generally found to be safe, although further research is needed to investigate both the efficacy and safety of high dose therapy with inhaled corticosteroids. Studies have reported associations between the use of systemic corticosteroids and adverse perinatal outcomes, such as preterm birth, low birth weight, and pre-eclampsia. This must, however, be weighed against the potential serious impact of severe, uncontrolled asthma itself on pregnancy outcome. The main obstacle to a valid interpretation of several of the available studies is the inadequate stratification for asthma severity and control. Overall, asthma in itself and not just poor asthma control poses a greater risk to pregnancy outcomes than asthma medication. Nonetheless, more studies focusing on disentangling the effects of asthma alone and asthma medications are needed. Increased use of stratified risk assessments, taking the concept of asthma severity into greater consideration, is much warranted in future studies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.